| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 10/10/2007 | CN100341862C Thiazolidine derivative and medicinal use thereof |
| 10/10/2007 | CN100341852C Sulfur-bearing unsaturated carboxylic ester compound and use thereof |
| 10/10/2007 | CN100341496C Preventive or therapeutic agent for kidney disease |
| 10/09/2007 | US7279593 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 10/09/2007 | US7279582 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy |
| 10/09/2007 | US7279578 Use as orexin receptor antagonists, depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis; depressive neurosis; anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; schizophrenia; manic depression; delerium |
| 10/09/2007 | US7279493 cyanoiminopiperazines which inhibit vanilloid receptor 1 function in a cell |
| 10/09/2007 | US7279478 Cathepsin cysteine protease inhibitors |
| 10/09/2007 | US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 10/09/2007 | US7279467 Benzothiazole-and benzoxazole-4, 7-dione derivatives and their use as dcd25 phosphatase inhibitors |
| 10/04/2007 | WO2007111345A1 Reactive oxygen determination reagent |
| 10/04/2007 | WO2007111323A1 Ureide derivative and use thereof for medical purposes |
| 10/04/2007 | WO2007111179A1 Diagnostic imaging agent for incurable neuron disease |
| 10/04/2007 | WO2007110364A1 Benzothiazoles having histamine h3 receptor activity |
| 10/04/2007 | WO2007095601A3 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 10/04/2007 | WO2007060215A3 (r)-arylkylamino derivatives and pharmaceutical compositions containing them |
| 10/04/2007 | WO2005060694A3 Treatment of neurologic disorders with inhibitors of 11beta-hsd1 |
| 10/04/2007 | US20070232664 Iron binding agents |
| 10/04/2007 | US20070232614 Therapeutic Agent for Nonviral Hepatitis |
| 10/04/2007 | US20070232606 Compounds and Compositions as Cathepsin S Inhibitors |
| 10/04/2007 | US20070232601 Vla-4 Inhibitor |
| 10/04/2007 | US20070232586 Hydrazino-Substituted Heterocyclic Nitrile Compounds and Use Thereof |
| 10/04/2007 | US20070232574 2-Oxothiazolidine 4-Carboxylic acid compounds for promoting desquamation of the skin |
| 10/04/2007 | DE102006014335A1 Verdichtung von Sauerstoff Compression of oxygen |
| 10/04/2007 | CA2681639A1 Compounds and methods for treatment of disorders associated with er stress |
| 10/04/2007 | CA2647603A1 Ureide derivative and use thereof for medical purposes |
| 10/04/2007 | CA2645581A1 Benzothiazoles having histamine h3 receptor activity |
| 10/03/2007 | EP1838308A1 [4-(heteroaryl)piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 10/03/2007 | EP1519932B1 Bisarylsulfonamide compounds and their use in cancer therapy |
| 10/03/2007 | EP1042307B1 Aminothiazole inhibitors of cyclin dependent kinases |
| 10/03/2007 | CN101048418A Pi3-kinase |
| 10/03/2007 | CN101048374A Mercaptoamides as histone deacetylase inhibitors |
| 10/03/2007 | CN101048158A Thiazole based inhibitors of ATP-utilizing enyzmes |
| 10/03/2007 | CN101045715A Heterocycle inhibitor for glycogen synthase kinase gsk-3 |
| 10/03/2007 | CN100340548C Novel arylheteroalkylamine derivatives |
| 10/02/2007 | US7276612 For hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides |
| 10/02/2007 | US7276526 Comprising a cyclopropyl, and aryl or heteroaryl substitutions; treating neurological and psychological disorders |
| 10/02/2007 | US7276518 For therapy of neuropathic or chronic pain |
| 10/02/2007 | CA2203417C Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis |
| 09/27/2007 | WO2007109786A2 Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones |
| 09/27/2007 | WO2007108483A1 N-2-(hetero)arylethylcarboxamide derivative, and pest-controlling agent comprising the same |
| 09/27/2007 | WO2007107356A1 Method for preparing doped organic semiconductor materials and formulation utilized therein |
| 09/27/2007 | WO2007107311A2 Organic sulphinic acid derivatives |
| 09/27/2007 | WO2007085356A3 Insecticidal (heteroarylalkyl)alkane thio and oxo amine derivatives |
| 09/27/2007 | US20070225504 Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones |
| 09/27/2007 | US20070225503 Ambient-temperature molten salts and process for producing the same |
| 09/27/2007 | US20070225329 Aryl aniline beta2 adrenergic receptor agonists |
| 09/27/2007 | US20070225327 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 09/27/2007 | US20070225294 2-[4-({[4-{[4-(4-acetylphenyl)-1-piperazinyl]methyl}-2-(4-fluorophenyl)-1,3-thiazol-5-yl]methyl}sulfanyl)-2-methylphenoxy]-2-methylpropanoic acid; dyslipidemia, syndrome X, hypercholesteremia, type II diabetes mellitus, type I diabetes, insulin resistance, hyperlipidemia, and obesity |
| 09/27/2007 | US20070225259 Novel Thiazole Inhibitors of Fructose 1,6-Bishosphatase |
| 09/27/2007 | US20070224447 Organometallic Complex, Luminescent Solid, Organic el Element and Organic el Display |
| 09/27/2007 | US20070220687 Bridged Monoazo Dyes |
| 09/27/2007 | CA2644303A1 Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones |
| 09/26/2007 | EP1837926A1 Heterocyclic radicals or diradicals and their dimers, oligomers, polymers, di-spiro and polycyclic derivatives as well as their use in organic semiconductor materials and electronic devices. |
| 09/26/2007 | EP1837330A1 Benzamide inhibitors of the P2X7 receptor |
| 09/26/2007 | EP1837024A2 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection |
| 09/26/2007 | EP1836176A1 MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEROF |
| 09/26/2007 | EP1836158A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation |
| 09/26/2007 | EP1742902B1 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof |
| 09/26/2007 | EP1699752B1 (hetero)cyclyl carboxanilides for controlling harmful fungi |
| 09/26/2007 | EP1406873B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 09/26/2007 | EP1276732B1 Amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation" |
| 09/26/2007 | CN101044128A Biphenyl thiazole carboxamides |
| 09/26/2007 | CN101044127A Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1 |
| 09/26/2007 | CN101041645A Benzothiazole azo compound, synthesizing method and usage thereof |
| 09/26/2007 | CN100339370C Process for manufacture of sulfenimide |
| 09/26/2007 | CN100339360C Process for producing aromatic nitrile compound |
| 09/25/2007 | US7273881 Bridged tricyclic (e.g., 9,10-ethanoanthracene) derivatives of (2-carbonylamino)thiazol-5-yloxoacetamides; treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity including obesity, diabetes, inflammatory and immune diseases |
| 09/25/2007 | US7273880 Selective NPY (Y5) antagonists |
| 09/25/2007 | US7273878 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 09/25/2007 | US7273866 2-aryl thiazole derivatives as KCNQ modulators |
| 09/25/2007 | US7273863 Benzophenones as inhibitors of reverse transcriptase |
| 09/25/2007 | US7273857 Fused ring compounds substituted with a 8-azabicyclo[3.2.1]octane(cyclo)alkylene group, including benzothiazolones, e.g., 3-[3-(3-Propyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-3H-benzothiazol-2-one; highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes |
| 09/25/2007 | CA2547947C Azole derivatives as active superoxide radical inhibitors |
| 09/25/2007 | CA2230199C Pyridazin-3-one derivatives, their use as a herbicide, and intermediates for their production |
| 09/20/2007 | WO2007106879A2 Process for preparing n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide and related metabolites thereof |
| 09/20/2007 | WO2007106469A2 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders |
| 09/20/2007 | WO2007106016A1 Bezothiazol derivatives as beta2 adrenoreceptor agonists |
| 09/20/2007 | WO2007105989A2 1-oxo-3-(1h-indole)-3-il-1,2,3,4-tetrahydroisoxynolines, methods for the production thereof, combinatoric library and focused library |
| 09/20/2007 | WO2007104144A1 Compounds, ionic liquids, molten salts and uses thereof |
| 09/20/2007 | WO2007084390A3 Histone deacetylase inhibitors |
| 09/20/2007 | US20070219377 Indolestyryl compound and high density recording media utilizing the same |
| 09/20/2007 | US20070219258 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 09/20/2007 | US20070219215 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both |
| 09/20/2007 | CA2646430A1 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders |
| 09/20/2007 | CA2646223A1 Novel heterocyclic nf-kb inhibitors |
| 09/20/2007 | CA2644014A1 Bezothiazol derivatives as beta2 adrenoreceptor agonists |
| 09/19/2007 | EP1833809A1 New benzothiazolecarboxamides |
| 09/19/2007 | EP1833808A1 New benzothiazolesulfonamides |
| 09/19/2007 | EP1833807A1 Ubiquitin ligase inhibitors |
| 09/19/2007 | EP1833805A1 New 3-phenylpropionic acid derivatives for the treatment of diabetes |
| 09/19/2007 | EP1480976B1 Thiazole derivatives as npy receptor antagonists |
| 09/19/2007 | EP1406605B1 Carbamates of 2-heterocyclic-1,2-ethanediols |
| 09/19/2007 | EP1068211B1 Process for purification of a cephalosporin derivative |
| 09/19/2007 | CN101039914A Trifluoromethyl substituted benzamide as kinase inhibitors |
| 09/19/2007 | CN101037421A 4-(2-Benzothiazolyl aminoiminomethyl) phenoxyacetic acid and cupric complexes and preparation methods thereof |
| 09/19/2007 | CN101037420A New crystal type of netoglitazone and preparation method thereof |
| 09/19/2007 | CN101036648A Liquid formulations for dermal application in treatment of parasitic insects in animals |
| 09/19/2007 | CN100338073C Substituted phenylacetic acids |
| 09/19/2007 | CN100338057C Halogenated nitrobutadienes for controlling animal pests |